Jemma C Hopewell

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study
    Jemma C Hopewell
    Clinical Trial Service Unit, University of Oxford, Oxford, England
    Circ Cardiovasc Genet 4:68-73. 2011
  2. ncbi No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study
    Jemma C Hopewell
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK
    J Am Coll Cardiol 57:2000-7. 2011
  3. ncbi Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study
    Sarah Parish
    Heart Protection Study, Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Bldg, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK
    Circulation 125:2469-78. 2012
  4. ncbi Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias
    Robert Clarke
    Clinical Trial Service Unit and Epidemiological Studies Unit CTSU, University of Oxford, Oxford, UK
    PLoS Med 9:e1001177. 2012
  5. ncbi Genetic variants associated with Lp(a) lipoprotein level and coronary disease
    Robert Clarke
    Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom
    N Engl J Med 361:2518-28. 2009

Detail Information

Publications6

  1. ncbi Lipoprotein(a) genetic variants associated with coronary and peripheral vascular disease but not with stroke risk in the Heart Protection Study
    Jemma C Hopewell
    Clinical Trial Service Unit, University of Oxford, Oxford, England
    Circ Cardiovasc Genet 4:68-73. 2011
    ....
  2. ncbi No impact of KIF6 genotype on vascular risk and statin response among 18,348 randomized patients in the heart protection study
    Jemma C Hopewell
    Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK
    J Am Coll Cardiol 57:2000-7. 2011
    ..The aim of this study was to test the effects of the KIF6 Trp719Arg polymorphism (rs20455) on vascular risk and response to statin therapy in 18,348 participants from the Heart Protection Study...
  3. ncbi Lipids and lipoproteins and risk of different vascular events in the MRC/BHF Heart Protection Study
    Sarah Parish
    Heart Protection Study, Clinical Trial Service Unit and Epidemiological Studies Unit, Richard Doll Bldg, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK
    Circulation 125:2469-78. 2012
    ..Low-density lipoprotein (LDL) cholesterol and high-density lipoprotein (HDL) cholesterol are established risk factors for vascular disease, but lipoprotein particle concentrations may be stronger determinants of risk...
  4. ncbi Homocysteine and coronary heart disease: meta-analysis of MTHFR case-control studies, avoiding publication bias
    Robert Clarke
    Clinical Trial Service Unit and Epidemiological Studies Unit CTSU, University of Oxford, Oxford, UK
    PLoS Med 9:e1001177. 2012
    ....
  5. ncbi Genetic variants associated with Lp(a) lipoprotein level and coronary disease
    Robert Clarke
    Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom
    N Engl J Med 361:2518-28. 2009
    ..The genetic determinants of the Lp(a) lipoprotein level and their relevance for the risk of coronary disease are incompletely understood...